Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optimized Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07140133
What this trial is testing

Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient

Who this might be right for
High Bleeding Risk PatientsCardiologyStent Implantation+1 more
University Hospital, Grenoble 1,200
Not applicableUnknownNCT05059418
What this trial is testing

Burning Mouth Syndrome - New Diagnostic Criteria and Treatment

Who this might be right for
Burning Mouth Syndrome
Malmö University 40
Large-scale testing (Phase 3)Study completedNCT00265824
What this trial is testing

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 700
Not applicableUnknownNCT04338919
What this trial is testing

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary Intervention
Fujian Medical University 2,020
Large-scale testing (Phase 3)Study completedNCT00255099
What this trial is testing

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

Who this might be right for
HIV
Tibotec Pharmaceuticals, Ireland 593
Large-scale testing (Phase 3)Study completedNCT01335698
What this trial is testing

Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients

Who this might be right for
HIV
Bristol-Myers Squibb 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT07507214
What this trial is testing

Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion

Who this might be right for
ConcussionDepression
University of Florida 35
Testing effectiveness (Phase 2)Study completedNCT00022763
What this trial is testing

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT00967187
What this trial is testing

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.

Who this might be right for
HIV Infections
Myrexis Inc. 32
Testing effectiveness (Phase 2)UnknownNCT00072553
What this trial is testing

Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicableStudy completedNCT01190124
What this trial is testing

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

Who this might be right for
HIV Infections
Doroana, Maria Manuela, M.D. 151
Large-scale testing (Phase 3)Ended earlyNCT00197197
What this trial is testing

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

Who this might be right for
HIV Infection
GlaxoSmithKline 18
Post-approval studies (Phase 4)Study completedNCT05583838
What this trial is testing

Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Who this might be right for
Previously Treated Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 157
Not applicableStudy completedNCT02053857
What this trial is testing

Pilot Study of PUFA-optimized RUTF for Severe Acute Malnutrition

Who this might be right for
KwashiorkorMarasmus
Washington University School of Medicine 141
Large-scale testing (Phase 3)UnknownNCT05575518
What this trial is testing

A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

Who this might be right for
TuberculosisHuman Immunodeficiency Virus
Stellah Mpagama 414
Not applicableStudy completedNCT05236478
What this trial is testing

Efficiency of an Optimized Care Organization for Fatigue Management for Patients With COVID-19.

Who this might be right for
COVID-19Fatigue
Centre Hospitalier Universitaire de Saint Etienne 17
Testing effectiveness (Phase 2)Ended earlyNCT00300573
What this trial is testing

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Incyte Corporation 250
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Not applicableLooking for participantsNCT04709900
What this trial is testing

CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes

Who this might be right for
Coronary Artery DiseaseChest SyndromeAcute Myocardial Infarction+3 more
Rigshospitalet, Denmark 2,000
Large-scale testing (Phase 3)Study completedNCT01262651
What this trial is testing

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

Who this might be right for
PainAdvanced Cancer
GW Pharmaceuticals Ltd 397
Next Page